AIDS Community Information Outreach Projects
-
Funding opportunities for outreach efforts to community-based AIDS organizations and patient advocacy groups. The primary purpose of these outreach projects is to design local programs for improving information access for AIDS patients and the affected community as well as their caregivers.
(National Library of Medicine (NLM), NIH)
AIDS and HIV Funding
-
Summaries of national and state funding programs related to AIDS and HIV.
(Rural Health Information Hub)
Advancing HIV/AIDS Research within the Mission of the NIDCD (R01 Clinical Trial Optional)
-
The purpose of this Funding Opportunity Announcement (FOA) is to stimulate HIV/AIDS research within the scientific mission areas of the National Institute on Deafness and Other Communications Disorders (NIDCD). Applications should address high priority HIV/AIDS research outlined by the NIH Office of AIDS Research (OAR) [https://www.oar.nih.gov/hiv-policy-and-research/research-priorities] in the areas of hearing, balance, taste, smell, voice, speech, and language.
(National Institute on Deafness and Other Communication Disorders (NIDCD), NIH)
Advancing HIV/AIDS Research within the Mission of the NIDCD (R21 Clinical Trial Optional)
-
The purpose of this Funding Opportunity Announcement (FOA) is to stimulate HIV/AIDS research within the scientific mission areas of the National Institute on Deafness and Other Communications Disorders (NIDCD). Applications should address high priority HIV/AIDS research outlined by the NIH Office of AIDS Research (OAR) [https://www.oar.nih.gov/hiv-policy-and-research/research-priorities] in the areas of hearing, balance, taste, smell, voice, speech, and language.
(National Institutes of Health (NIH), HHS)
CDC HIV Funding Opportunities
-
Information on locating and applying for current CDC HIV funding opportunities and grants.
(Centers for Disease Control and Prevention (CDC), HHS)
Centers for AIDS Research (P30 Clinical Trial Not Allowed)
-
The purpose of this Funding Opportunity Announcement (FOA) is to invite applications for the Centers for AIDS Research (CFAR) program to provide administrative and shared research support to enhance HIV/AIDS research. CFARs provide core facilities, expertise, resources, and services not readily obtained otherwise through more traditional funding mechanisms. The program emphasizes interdisciplinary collaboration across all areas of HIV/AIDS research.
(National Institutes of Health (NIH), HHS)
Chart of Available Infectious Disease Grants
-
A living document updated regularly that lists several opportunities for states and public health departments to apply for grants to fund programs and nfrastructure to address the rising rates of infectious disease in relation to the opioid epidemic.
(National Alliance of State and Territorial AIDS Directors (NASTAD))
Comer Foundation Syringe Access Program
-
The Comer Foundation provides support to not-for-profit organizations focused on syringe exchange and other harm reduction strategies within the drug using community and seeks to facilitate the process between organizations and communities committed to creating and maintaining health.
(The Comer Foundation)
Control of Sexually Transmitted Infections (STIs) Through a Comprehensive Understanding of the Natural History of Infection (R01 Clinical Trial Not Allowed)
-
Funding for research to advance the understanding of natural history of infection for three sexually transmitted infections (STIs): gonorrhea, syphilis, and chlamydia. This research opportunity encourages studies that address the natural history of infection in the context of either: 1) correlates of protection, 2) host response to infection, 3) clinical endpoints of disease, or 4) biological and clinical factors that influence clearance rather than persistence of infection.
(National Institutes of Health (NIH), HHS)
Dental Reimbursement Program
-
The Ryan White HIV/AIDS Program (RWHAP) Part F Dental Reimbursement Program (DRP) improves access to oral health care services for low-income, uninsured and underserved people living with HIV (PLWH) and trains dental and hygiene students and dental residents to deliver dental care to PLWH. The DRP accomplishes this by defraying a portion of unreimbursed dental care costs for low-income, uninsured, and underserved PLWH incurred by accredited dental or dental hygiene education programs recognized by the Commission on Dental Accreditation.
(Health Resources and Services Administration (HRSA), HHS)
Developmental Centers for AIDS Research (P30 Clinical Trial Not Allowed)
-
The purpose of this Funding Opportunity Announcement (FOA) is to invite applications for the Developmental Centers for AIDS Research (D-CFAR) program to provide administrative and shared research support to enhance HIV/AIDS research. D-CFARs provide core facilities, expertise, resources, and services not readily obtained otherwise through more traditional funding mechanisms. Additionally, D-CFARs provide support to assist investigators in the development of a competitive standard CFAR. The program emphasizes interdisciplinary collaboration across all areas of HIV/AIDS research.
(National Institutes of Health (NIH), HHS)
Engaging Men in HIV Testing, Prevention, and Care (R01 Clinical Trial Optional)
-
Funding to develop and test strategies to increase the engagement of men in HIV prevention and care within global settings and among US domestic populations who have evidenced lower rates of engagement and retention in HIV prevention and care.
(National Institutes of Health (NIH), HHS)
Engaging Men in HIV Testing, Prevention, and Care (R21 Clinical Trial Optional)
-
Funding to develop and test strategies to increase the engagement of men in HIV prevention and care within global settings and among US domestic populations who have evidenced lower rates of engagement and retention in HIV prevention and care.
(National Institutes of Health (NIH), HHS)
Engineering Immunity to HIV-1 Through Next Generation Vaccines (R61/R33 Clinical Trial Not Allowed)
-
The objective of this Funding Opportunity Announcement (FOA) is to pair Bioengineers and Immunologists to leverage emerging innovative knowledge in physical and computational sciences for the design and development of an HIV-1 vaccine.
(National Institutes of Health (NIH), HHS)
Fogarty HIV Research Training Program for Low-and Middle-Income Country Institutions (D43 Clinical Trial Optional)
-
The purpose of this FOA is to encourage applications for research training programs to strengthen the scientific capacity of institutions in low- and middle-income countries (LMICs) to conduct HIV research relevant to the evolving HIV epidemic in their country
(Fogarty International Center, NIH)
Formative and Pilot Intervention Research for Prevention and Treatment of HIV/AIDS (R34 Clinical Trial Optional)
-
Funding for formative research, intervention development, and pilot-testing of interventions. Primary scientific areas of focus include the feasibility, tolerability, acceptability and safety of novel or adapted interventions that target HIV prevention or treatment.
(National Institutes of Health (NIH), HHS)
Getting To Zero: Understanding HIV Viral Suppression and Transmission in the United States (R01 Clinical Trial Optional)
-
The purpose of this Funding Opportunity Announcement (FOA) is to support grants to improve understanding of viral suppression and HIV transmission in the United States (U.S.) using population-level epidemiology, novel tools from data science approaches and m/eHealth, and implementation science research. Data generated through this research will be used to inform and evaluate context-specific HIV control strategies towards the goal of ending the HIV epidemic in the U.S.
(National Institutes of Health (NIH), HHS)
HIV Vaccine Research and Design (HIVRAD) Program (P01 Clinical Trial Not Allowed)
-
The purpose of this Funding Opportunity Announcement (FOA) is to support multi-component, multi-disciplinary projects that address scientific questions relevant to AIDS prophylactic vaccine discovery research. Extensive evaluation of vaccine concepts in non-human primate models may be included.
(National Institutes of Health (NIH), HHS)
HIV Vaccine Trials Network Research and Mentorship Program (RAMP) Scholar Program for African-American and Latinx Medical Students
-
The HIV Vaccine Trials Network, in collaboration with the National Institute of Mental Health, the National Institute of Allergy and Infectious Diseases, and the Bill & Melinda Gates Foundation is investing in the next generation of HIV prevention researchers by providing African American and Latinx medical students with opportunities for independent research along with structured mentoring, project and salary funding, training, and professional development activities.
(HIV Vaccine Trials Network)
HIV/AIDS Funding
-
The foundation focuses its grantmaking on strategies to help significantly slow and prevent the global spread of HIV.
(Bill & Melinda Gates Foundation)
Harnessing Big Data to Halt HIV (R01 Clinical Trial Optional)
-
Funding to promote research that transforms understanding of HIV transmission, the HIV care continuum, and HIV comorbidities using Big Data Science (BDS).
(National Institutes of Health (NIH), HHS)
Implementing and Evaluating a Data-to-Care Rx Strategy
-
The purpose of this notice of funding opportunity (NOFO) is to: 1) utilize real-time prescription data to identify HIV-infected patients who are late filling their antiretroviral (ARV) prescriptions and to target these individuals for progressive adherence and retention interventions; 2) to determine the essential steps and critical elements for conducting a Data-to-Care Rx (D2C Rx) strategy; and 3) develop a D2C Rx implementation protocol and other implementation materials. The objectives of the NOFO are to improve HIV viral suppression, adherence to ARV therapy and retention in care.
Infrastructure Development Training Programs for Critical HIV Research at Low-and Middle-Income Country Institutions (G11 Clinical Trials Not Allowed)
-
The overall goal of the Fogarty International Center (FIC) HIV Research Training Program is to strengthen the scientific capacity of institutions in low- and middle-income countries (LMICs) to conduct HIV research on the evolving HIV epidemic in their countries.
(Fogarty International Center, NIH)
Innovation for HIV Vaccine Discovery (R01 Clinical Trial Not Allowed)
-
The purpose of this Funding Opportunity Announcement (FOA) is to support high risk, high impact, early discovery research on vaccine approaches to prevent acquisition of or ongoing infection by HIV. In keeping with the high risk, high impact nature of this research, this FOA supports a Go/No-Go approach to funding high risk research, which is significantly different from most R01 projects. Continued funding for the full award duration is dependent upon achieving negotiated “Go/No-Go” criteria by the end of Year 2.
(National Institutes of Health (NIH), HHS)
Innovations in HIV Prevention, Testing, Adherence and Retention to Optimize HIV Prevention and Care Continuum Outcomes (R01 Clinical Trial Optional)
-
This FOA solicits innovative research to optimize HIV prevention and care which is aligned with NIMH Division of AIDS Research (DAR) priorities. Applications may include formative basic behavioral and social science to better understand a step or steps in the HIV prevention or care continuum, and/or the initial development and pilot testing of innovative intervention approaches, and intervention efficacy or effectiveness trials. Applicants are encouraged to read current Notices of Special Interests (NOSIs) from NIMH DAR for further information about the Divisions research priorities.
(National Institutes of Health (NIH), HHS)
Innovations in HIV Prevention, Testing, Adherence and Retention to Optimize HIV Prevention and Care Continuum Outcomes (R21 Clinical Trial Optional)
-
This Funding Opportunity Announcement (FOA) solicits innovative research to optimize HIV prevention and care which is aligned with NIMH Division of AIDS Research (DAR) priorities. Applications may include formative basic behavioral and social science to better understand a step or steps in the HIV prevention or care continuum, and/or the initial development and pilot testing of innovative intervention approaches. Applicants are encouraged to read current Notices of Special Interests (NOSIs) from NIMH DAR for further information about the Divisions research priorities.
(National Institutes of Health (NIH), HHS)
Linking the Provider Recommendation to Adolescent HPV Vaccine Uptake (R01 Clinical Trial Optional)
-
Funding for research on how the healthcare delivery system enhances or inhibits the effectiveness of a provider's recommendation of the adolescent human papillomavirus (HPV) vaccine.
(National Institutes of Health (NIH), HHS)
Linking the Provider Recommendation to Adolescent HPV Vaccine Uptake (R03 Clinical Trial Optional)
-
This Funding Opportunity Announcement (FOA) encourages research on how the healthcare delivery system enhances or inhibits the effectiveness of a provider's recommendation of the adolescent human papillomavirus (HPV) vaccine. Characteristics of the provider, parent/patient, and clinical setting, can all affect whether a provider makes a recommendation, and whether that recommendation results in uptake of the HPV vaccine. This research requires expertise in cancer prevention, adult and childhood behavior, immunization promotion, and healthcare delivery.
(National Institutes of Health (NIH), HHS)
Linking the Provider Recommendation to Adolescent HPV Vaccine Uptake (R21 Clinical Trial Optional)
-
Funding for research on how the healthcare delivery system enhances or inhibits the effectiveness of a provider's recommendation of the adolescent human papillomavirus (HPV) vaccine.
(National Institutes of Health (NIH), HHS)
Multidisciplinary Studies of HIV/AIDS and Aging (R01 Clinical Trial Optional)
-
This FOA encourages applications at the intersection of HIV and aging by addressing two overarching objectives: 1) to improve understanding of biological, clinical, and socio-behavioral aspects of aging through the lens of HIV infection and its treatment; and 2) to improve approaches for testing, prevention, and treatment of HIV infection, and management of HIV-related comorbidities, co-infections, and complications in different populations and cultural settings by applying our current understanding of aging science.
(National Institutes of Health (NIH), HHS)
Multidisciplinary Studies of HIV/AIDS and Aging (R21 Clinical Trial Optional)
-
This FOA encourages exploratory/developmental research applications at the intersection of HIV and aging by addressing two overarching objectives: 1) to improve understanding of biological, clinical, and socio-behavioral aspects of aging through the lens of HIV infection and its treatment; and 2) to improve approaches for testing, prevention, and treatment of HIV infection, and management of HIV-related comorbidities, co-infections, and complications in different populations and cultural settings by applying our current understanding of aging science.
(National Institutes of Health (NIH), HHS)
NICHD Program Project Grants for HIV Research (P01 Clinical Trial Optional)
-
This Funding Opportunity Announcement (FOA) invites submission of Program Project (P01) applications to support integrated, multi-project research programs that address HIV scientific areas relevant to the NICHD mission as a well-defined, central research focus or objective.
(Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH)
NIDA Avant-Garde Award Program for HIV/AIDS and Substance Use Disorder Research (DP1, Clinical Trial Optional)
-
The NIDA Avant-Garde Award Program for HIV/AIDS Research supports exceptionally creative scientists, who propose high-impact research that will open new areas of HIV/AIDS research in the context of Substance Use Disorders (SUD) and/or lead to new avenues for prevention and treatment of HIV/AIDS in people who use drugs (PWUD).
(National Institute on Drug Abuse (NIDA), NIH)
National Prevention Information Network
-
Database for locating public and private funding for community-based organizations and HIV/AIDS prevention initiatives using a keyword search.
New Models of Integrated HIV/AIDS, Addiction, and Primary Care Services (R01 Clinical Trial Required)
-
The purpose of this FOA is to support the testing of enhanced models of care that optimally integrate HIV, addiction, and primary care services. NIDA is interested in research that addresses gaps related to the delivery of comprehensive, integrated health services to include the full continuum of HIV/AIDS services, addiction prevention and treatment services, and primary care services, with a goal of improving the coordination of care, and improving health outcomes related to HIV and SUD in the US.
(National Institute on Drug Abuse (NIDA), NIH)
New Models of Integrated HIV/AIDS, Addiction, and Primary Care Services (R34 - Clinical Trial Optional)
-
This funding opportunity announcement will support the development and testing of enhanced models of care that are able to optimally integrate HIV, addiction, and primary care services.
(National Institute on Drug Abuse (NIDA), NIH)
Partnering and Communicating Together
-
The intent of this NOFO is to develop, disseminate, and monitor HIV communication messages through strategic partnerships. Given that there are limited resources to devote to partner activities, the NOFO focuses efforts on communities highly impacted by HIV (e.g., gay and bisexual men, transgender women, black/African American communities, Hispanic/Latino communities and youth and emerging adults) and in jurisdictions where the epidemic is most prevalent and new infections are taking place.
(Centers for Disease Control and Prevention (CDC), HHS)
Planning Grant for Fogarty HIV Research Training Program for Low- and Middle-Income Country Institutions (D71 Clinical Trial Not Allowed)
-
The overall goal of the Fogarty International Center (FIC) HIV Research Training Program is to strengthen the scientific capacity of institutions in low- and middle-income countries (LMICs) to conduct HIV research related to the evolving HIV epidemic in their country.
(Fogarty International Center, NIH)
Positive Women's Network Fellowship
-
The PWN Policy Fellowship is a year–long program structured to increase participant’s ability to engage effectively in federal, state and local policy and advocacy. It is critical that our community is equipped with a wide array of tools to support vibrant, visionary and strategic advocacy that helps craft a world where all women, transgender and gender non–conforming (TGNC) people living with HIV can live long, healthy and dignified lives free from stigma and discrimination.
Post-Doctoral Research Fellowships for HIV Prevention in Communities of Color
-
The mission of this fellowship program is to recruit, mentor, and train investigators to conduct domestic HIV and AIDS prevention research in communities of color.
(Centers for Disease Control and Prevention (CDC), HHS)
PrEP Choice: Increasing the Use of HIV Pre-exposure Prophylaxis in an Era of Choices
-
The purpose of this notice of funding opportunity is to conduct implementation research to understand the selection, adherence, persistence, and switching patterns associated with the use of FDA approved PrEP formulations by men who have sex with men (MSM). Two oral medications have been approved by the FDA as PrEP medications for MSM. Both are recommended for daily use, and one is also recommended for 2-1-1 use before and after sex rather than daily. An injectable long-acting PrEP medication that is administered every 2 months is expected to become available in 2022.
(Centers for Disease Control and Prevention (CDC), HHS)
Reducing Stigma to Improve HIV/AIDS Prevention, Treatment and Care in Low- and Middle-Income Countries
-
Reducing Stigma to Improve HIV/AIDS Prevention, Treatment and Care in Low- and Middle-Income Countries (LMICs) seeks to stimulate new and impactful research towards the development of stigma reduction interventions leading to better outcomes for the prevention and treatment of HIV/AIDS and on the quality of life of People Living with HIV/AIDS (PLWH) in LMICs.
(Fogarty International Center, NIH)
Research Towards Developing a Cure for HBV in HIV/HBV Co-Infection (R21 Clinical Trial Not Allowed)
-
The purpose of this Funding Opportunity Announcement (FOA) is to invite applications for support of innovative basic, translational, and clinical research to identify and address the challenges to achieving hepatitis B virus (HBV) cure in the presence of human immunodeficiency virus (HIV.
(National Institutes of Health (NIH), HHS)
Ryan White & HIV/AIDS Program
-
The Ryan White HIV/AIDS Program works with cities, states, and local community-based organizations to provide services to people who do not have sufficient health care coverage or financial resources to cope with HIV disease.
(Health Resources and Services Administration (HRSA), HHS)
Sustained Release of Antivirals for Treatment or Prevention of HIV (SRATP) (R01 Clinical Trial Not Allowed)
-
The purpose of this Funding Opportunity Announcement (FOA) is to encourage grant applications that address the long term goal and objective of developing sustained release strategies for HIV treatment or prevention.
(National Institutes of Health (NIH), HHS)
The Kent Richard Hofmann Foundation Grants
-
Foundation provides grants to community-based organizations in support of care and direct services, education, and research for HIV/AIDS, with a focus on smaller and rural communities.
Transgender People: Immunity, Prevention, and Treatment (R21 Clinical Trial Not Allowed)
-
The purpose of this Funding Opportunity Announcement (FOA) is to support hypothesis-generating research in transgender people with the objective of characterizing the biological and immunological impact of the interventions (hormones, drugs and surgical) used for gender reassignment and their impact on susceptibility to HIV and other sexually transmitted infections (STI).
(National Institutes of Health (NIH), HHS)
Using Innovative Intervention Strategies to Improve Health Outcomes among People with HIV - Coordinating Center
-
The goal of this four-year cooperative agreement is to identify and provide support for the implementation of evidence-informed interventions to reduce HIV-related health disparities and improve health outcomes, including increasing retention in care, improving treatment adherence, and improving viral suppression for PLWH. The project will focus on implementing effective and culturally appropriate evidence-informed interventions that will be tailored to meet the needs of the target populations, using the framework of implementation science, and assessing and adapting the interventions at interim intervals throughout the project period
(Health Resources and Services Administration (HRSA), HHS)
Using Innovative Intervention Strategies to Improve Health Outcomes among People with HIV - Evaluation Center
-
The goal of this four-year cooperative agreement is to evaluate the outcomes and impact of the evidence-informed interventions implemented through the companion initiative entitled Using Evidence-Informed Interventions to Improve Health Outcomes among People Living with HIV – Coordinating Center for Technical Assistance (E2i CCTA), funded under HRSA-17-044.
(Health Resources and Services Administration (HRSA), HHS)
amfAR Public Policy Awards
-
The page listing for amfAR's public policy grants.
(American Foundation for AIDS Research (amfAR))